Cargando…

Life beyond 5 Years after TAVI: Patients' Perceived Health Status and Long-Term Outcome after Transcatheter Aortic Valve Implantation

BACKGROUND: Transcatheter aortic valve implantation (TAVI) is currently recommended for patients with severe aortic stenosis at intermediate or high surgical risk. The decision process during TAVI evaluation includes a thorough benefit-risk assessment, and knowledge about long-term benefits and outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Marie-Isabel K., Hofmann, Eileen, De Rosa, Roberta, Mas-Peiro, Silvia, Seppelt, Philipp, Walther, Thomas, Zeiher, Andreas M., Fichtlscherer, Stephan, Vasa-Nicotera, Mariuca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794985/
https://www.ncbi.nlm.nih.gov/pubmed/31772530
http://dx.doi.org/10.1155/2019/4292987
_version_ 1783459404100665344
author Murray, Marie-Isabel K.
Hofmann, Eileen
De Rosa, Roberta
Mas-Peiro, Silvia
Seppelt, Philipp
Walther, Thomas
Zeiher, Andreas M.
Fichtlscherer, Stephan
Vasa-Nicotera, Mariuca
author_facet Murray, Marie-Isabel K.
Hofmann, Eileen
De Rosa, Roberta
Mas-Peiro, Silvia
Seppelt, Philipp
Walther, Thomas
Zeiher, Andreas M.
Fichtlscherer, Stephan
Vasa-Nicotera, Mariuca
author_sort Murray, Marie-Isabel K.
collection PubMed
description BACKGROUND: Transcatheter aortic valve implantation (TAVI) is currently recommended for patients with severe aortic stenosis at intermediate or high surgical risk. The decision process during TAVI evaluation includes a thorough benefit-risk assessment, and knowledge about long-term benefits and outcomes may improve patients' expectation management. OBJECTIVE: To evaluate patients' perceived health status and self-reported long-term outcome more than 5 years after TAVI. METHODS AND RESULTS: Demographic and procedure data were obtained from all patients treated with TAVI at our institution from 2006 to 2012. A cross-sectional survey was conducted on the patients alive, measuring health status, including the EQ-5D-5L questionnaire, and clinical outcomes. 103 patients (22.8%) were alive at a median follow-up period of 7 years (5.4–9.8). 99 (96%) of the 103 patients were included in the final analysis. The mean age at follow-up was 86.5 years ± 8.0 years, and 56.6% were female. Almost all patients (93.9%) described an improvement of their quality of life after receiving TAVI. At late follow-up, the mean utility index and EQ-VAS score were 0.80 ± 0.20 and 58.49 ± 11.49, respectively. Mobility was found to be the most frequently reported limitation (85.4%), while anxiety/depression was the least frequently reported limitation (19.8%). With respect to functional class, 64.7% were in New York Heart Association (NYHA) class III or IV, compared to 67.0% prior to TAVI (p=0.51). Self-reported long-term outcomes revealed mainly low long-term complication rates. 74 total hospitalizations were reported after TAVI, and among those 43% for cardiovascular reasons. Within cardiovascular rehospitalizations, new pacemaker implantations were the most frequently reported (18.9%), followed by cardiac decompensation and coronary heart disease (15.6%). CONCLUSION: The majority of the patients described an improvement of health status after TAVI. More than five years after TAVI, the patients' perceived health status was satisfactory, and the incidence of clinical events and hospitalizations was very low.
format Online
Article
Text
id pubmed-6794985
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-67949852019-10-21 Life beyond 5 Years after TAVI: Patients' Perceived Health Status and Long-Term Outcome after Transcatheter Aortic Valve Implantation Murray, Marie-Isabel K. Hofmann, Eileen De Rosa, Roberta Mas-Peiro, Silvia Seppelt, Philipp Walther, Thomas Zeiher, Andreas M. Fichtlscherer, Stephan Vasa-Nicotera, Mariuca J Interv Cardiol Clinical Study BACKGROUND: Transcatheter aortic valve implantation (TAVI) is currently recommended for patients with severe aortic stenosis at intermediate or high surgical risk. The decision process during TAVI evaluation includes a thorough benefit-risk assessment, and knowledge about long-term benefits and outcomes may improve patients' expectation management. OBJECTIVE: To evaluate patients' perceived health status and self-reported long-term outcome more than 5 years after TAVI. METHODS AND RESULTS: Demographic and procedure data were obtained from all patients treated with TAVI at our institution from 2006 to 2012. A cross-sectional survey was conducted on the patients alive, measuring health status, including the EQ-5D-5L questionnaire, and clinical outcomes. 103 patients (22.8%) were alive at a median follow-up period of 7 years (5.4–9.8). 99 (96%) of the 103 patients were included in the final analysis. The mean age at follow-up was 86.5 years ± 8.0 years, and 56.6% were female. Almost all patients (93.9%) described an improvement of their quality of life after receiving TAVI. At late follow-up, the mean utility index and EQ-VAS score were 0.80 ± 0.20 and 58.49 ± 11.49, respectively. Mobility was found to be the most frequently reported limitation (85.4%), while anxiety/depression was the least frequently reported limitation (19.8%). With respect to functional class, 64.7% were in New York Heart Association (NYHA) class III or IV, compared to 67.0% prior to TAVI (p=0.51). Self-reported long-term outcomes revealed mainly low long-term complication rates. 74 total hospitalizations were reported after TAVI, and among those 43% for cardiovascular reasons. Within cardiovascular rehospitalizations, new pacemaker implantations were the most frequently reported (18.9%), followed by cardiac decompensation and coronary heart disease (15.6%). CONCLUSION: The majority of the patients described an improvement of health status after TAVI. More than five years after TAVI, the patients' perceived health status was satisfactory, and the incidence of clinical events and hospitalizations was very low. Hindawi 2019-10-01 /pmc/articles/PMC6794985/ /pubmed/31772530 http://dx.doi.org/10.1155/2019/4292987 Text en Copyright © 2019 Marie-Isabel K. Murray et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Murray, Marie-Isabel K.
Hofmann, Eileen
De Rosa, Roberta
Mas-Peiro, Silvia
Seppelt, Philipp
Walther, Thomas
Zeiher, Andreas M.
Fichtlscherer, Stephan
Vasa-Nicotera, Mariuca
Life beyond 5 Years after TAVI: Patients' Perceived Health Status and Long-Term Outcome after Transcatheter Aortic Valve Implantation
title Life beyond 5 Years after TAVI: Patients' Perceived Health Status and Long-Term Outcome after Transcatheter Aortic Valve Implantation
title_full Life beyond 5 Years after TAVI: Patients' Perceived Health Status and Long-Term Outcome after Transcatheter Aortic Valve Implantation
title_fullStr Life beyond 5 Years after TAVI: Patients' Perceived Health Status and Long-Term Outcome after Transcatheter Aortic Valve Implantation
title_full_unstemmed Life beyond 5 Years after TAVI: Patients' Perceived Health Status and Long-Term Outcome after Transcatheter Aortic Valve Implantation
title_short Life beyond 5 Years after TAVI: Patients' Perceived Health Status and Long-Term Outcome after Transcatheter Aortic Valve Implantation
title_sort life beyond 5 years after tavi: patients' perceived health status and long-term outcome after transcatheter aortic valve implantation
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794985/
https://www.ncbi.nlm.nih.gov/pubmed/31772530
http://dx.doi.org/10.1155/2019/4292987
work_keys_str_mv AT murraymarieisabelk lifebeyond5yearsaftertavipatientsperceivedhealthstatusandlongtermoutcomeaftertranscatheteraorticvalveimplantation
AT hofmanneileen lifebeyond5yearsaftertavipatientsperceivedhealthstatusandlongtermoutcomeaftertranscatheteraorticvalveimplantation
AT derosaroberta lifebeyond5yearsaftertavipatientsperceivedhealthstatusandlongtermoutcomeaftertranscatheteraorticvalveimplantation
AT maspeirosilvia lifebeyond5yearsaftertavipatientsperceivedhealthstatusandlongtermoutcomeaftertranscatheteraorticvalveimplantation
AT seppeltphilipp lifebeyond5yearsaftertavipatientsperceivedhealthstatusandlongtermoutcomeaftertranscatheteraorticvalveimplantation
AT waltherthomas lifebeyond5yearsaftertavipatientsperceivedhealthstatusandlongtermoutcomeaftertranscatheteraorticvalveimplantation
AT zeiherandreasm lifebeyond5yearsaftertavipatientsperceivedhealthstatusandlongtermoutcomeaftertranscatheteraorticvalveimplantation
AT fichtlschererstephan lifebeyond5yearsaftertavipatientsperceivedhealthstatusandlongtermoutcomeaftertranscatheteraorticvalveimplantation
AT vasanicoteramariuca lifebeyond5yearsaftertavipatientsperceivedhealthstatusandlongtermoutcomeaftertranscatheteraorticvalveimplantation